Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Применение наружной контрпульсации в комплексном лечении больных с хронической сердечной недостаточностью
Применение наружной контрпульсации в комплексном лечении больных с хронической сердечной недостаточностью
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Цель исследования заключалась в изучении возможности наружной контрапульсации (НКП) в комплексном лечении больных с хронической сердечной недостаточностью.
В исследование был включен 71 больной с ишемической болезнью сердца и хронической сердечной недостаточностью. Пациентов распределили на две группы – вмешательства и контрольную. Достоверных различий между больными обеих групп по основным клиническим и антропометрическим данным не наблюдалось.
Пациентам был проведен ряд исследований: ЭКГ, ЭхоКГ, проба D.Celemajer на эндотелийзависимую вазодилактацию, тетраполярная грудная импедансометрия, определение IV-концевого предшественника мозгового натрийуретического пептида, тест 6-минутной ходьбы.
Больные основной группы на фоне стандартного лечения получили 35 процедур НКП.
У больных группы вмешательства в 84% случаев НКП оказала дополнительный благоприятный клинический эффект, произошло улучшение эндотелиальной функции.
Ключевые слова: хроническая сердечная недостаточность, наружная контрапульсация, эндотелиальная дисфункция, натрийуретический пептид.
Materials and methods. The study included 71 patients with coronary artery disease and heart failure. They were distributed in the intervention group and control group. No significant differences between patients in both groups on the main clinical and anthropometric data were observed.
Used methods. ECG, echocardiography, the Celemajer D test on endothelium-dependent vasodilation, tetrapolar chest impedansometriya, the definition of IV-terminal brain natriuretic peptide precursor, six-minute walk test.
Intervention. The main group of patients against a background of standard treatment received 35 procedures of an external counterpulsation therapy (ECP).
Results. In patients of the intervention group in 84% of cases ECP provided additional clinical benefit, as well as improvement in endothelial function occurred.
Key words: chronic heart failure, external counterpulsation, endothelial dysfunction, natriuretic peptide.
В исследование был включен 71 больной с ишемической болезнью сердца и хронической сердечной недостаточностью. Пациентов распределили на две группы – вмешательства и контрольную. Достоверных различий между больными обеих групп по основным клиническим и антропометрическим данным не наблюдалось.
Пациентам был проведен ряд исследований: ЭКГ, ЭхоКГ, проба D.Celemajer на эндотелийзависимую вазодилактацию, тетраполярная грудная импедансометрия, определение IV-концевого предшественника мозгового натрийуретического пептида, тест 6-минутной ходьбы.
Больные основной группы на фоне стандартного лечения получили 35 процедур НКП.
У больных группы вмешательства в 84% случаев НКП оказала дополнительный благоприятный клинический эффект, произошло улучшение эндотелиальной функции.
Ключевые слова: хроническая сердечная недостаточность, наружная контрапульсация, эндотелиальная дисфункция, натрийуретический пептид.
________________________________________________
Materials and methods. The study included 71 patients with coronary artery disease and heart failure. They were distributed in the intervention group and control group. No significant differences between patients in both groups on the main clinical and anthropometric data were observed.
Used methods. ECG, echocardiography, the Celemajer D test on endothelium-dependent vasodilation, tetrapolar chest impedansometriya, the definition of IV-terminal brain natriuretic peptide precursor, six-minute walk test.
Intervention. The main group of patients against a background of standard treatment received 35 procedures of an external counterpulsation therapy (ECP).
Results. In patients of the intervention group in 84% of cases ECP provided additional clinical benefit, as well as improvement in endothelial function occurred.
Key words: chronic heart failure, external counterpulsation, endothelial dysfunction, natriuretic peptide.
Полный текст
Список литературы
1. Бокерия Л.А. Алекян Б.Г., Асланиди И.П. и др. Важное значение метода усиленной наружной контрпульсации в комплексной терапии на различных этапах лечения у пациентов с дистальным поражением коронарного русла. Бюлл. НЦ ССХ им. А.Н.Бакулева РАМН. 2009; 6 (Прил.): 296.
2. Бокерия Л.А. Ермоленко М.Л., Байрамукова М.Х. Наружная контрпульсация – эффективный метод лечения рефрактерной стенокардии. Бюлл. НЦ ССХ им. А.Н.Бакулева РАМН. 2005; 4: 5–10.
3. Бузиашвили Ю.И. Камардинов Д.Х., Мацкеплишвили С.Т. и др. Возможности наружной контрпульсации в комплексном лечении больных с ишемической болезнью сердца. Бюлл. НЦ ССХ им. А.Н.Бакулева РАМН. 2009; 1: 100–8.
4. Голухова, Е.З. Теряева Н.Б., Алиева А.М. Натрийуретические пептиды – маркеры и факторы прогноза при хронической сердечной недостаточности. Креативная кардиология. 2007; 1–2: 126–36.
5. Национальные рекомендации по диагностике и лечению ХСН (2-й пересмотр; утверждены съездом кардиологов РФ в октябре 2003 г.) Сердечная недостаточность. 2003; 4 (6): 276–97.
6. Терещенко С.Н. Павликова Е.П., Мерай И.А. Место мозгового натрийуретического пептида в диагностике сердечной недостаточности. Сердечная недостаточность. 2003; 2: 103–4.
7. Ancheta IB, Battie C, Cobb S et al. The impact of B-type natriuretic peptide, New York Heart Association classification and depression on quality of life in nonhospitalized heart failure patients. Prog Cardiovasc Nurs 2009; 24 (4): 124–30.
8. Applebaum RM, Kasliwal R, Tunick PA et al. Sequential external counterpulsation 61increases cerebral and renal blood flow. Am Heart J 1997; 133: 611–5.
9. Arora R, Chou T, Jain D et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. JACC 1999; 33 (7): 1833–40.
10. Arora R, Shah A. The role of enhanced external counterpulsation in the treatment of angina and heart failure. Can J Cardiol 2007; 23 (10): 779–81.
11. Bondesson S, Pettersson T, Ohlsson O et al. Effects on blood pressure in patients with refractory angina pectoris after enhanced external counterpulsation. Blood Press 2010. Epub ahead of print.
12. Bonnetti P, Barsness G, Keelan P et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. JACC 2003; 41 (10): 1761–8.
13. Bonetti P, Gadasalli S, Lerman A, Barsness G. Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation. Clin Proc 2004; 79 (5): 690–2.
14. Bonetti P, Holmes D-Jr, Lerman A, Barsness G. Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? JACC 2003; 41 (11): 1918–25.
15. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168–75.
16. Brosche TA, Middleton SK, Boogaard RG. Enhanced external counter pulsation. Idimens Crit Care Nurs 2004; 23: 208–21.
17. Cai D, Wu R, Shao Y. Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med 2000; 23: 239–47.
18. Campbell AR, Satran D, Zenovich AG et al. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina. Am Heart J 2008; 156 (6): 1217–22.
19. Corson MA, James NL, Latta SE et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 1996; 79: 984–91.
20. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519–60.
21. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29 (19): 2388–442.
22. Dimmeler S, Fleming I, Fisslthaler B et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601–5.
23. Esmaeilzadeh M, Khaledifar A, Maleki M et al. Evaluation of left ventricular systolic and diastolic regional function after enhanced external counter pulsation therapy using strain rate imaging. Eur J Echocardiogr 2009; 10 (1): 120–6.
24. Estahbanaty G, Samiei N, Maleki M et al. Echocardiographic characteristics including tissue Doppler imaging after enhanced external counterpulsation therapy. Am Heart Hosp J 2007; 5 (4): 241–6.
25. Gorcsan J.-3rd, Crawford L, Soran O et al. Improvement in left ventricular performance by enhanced external counterpulsation in patients with heart failure. JACC 2000; 35: 230A (Suppl.).
26. Hashemi M, Hoseinbalam M, Khazaei M. Long-term effect of enhanced external counterpulsation on endothelial function in the patients with intractable angina. Heart Lung Circ 2008; 17 (5): 383–7.
27. Jessup M, Abraham W, Casey D et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119 (14): 1977–2016.
28. Karakiliç E, Kepez A, Abali G et al. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department. Anadolu Kardiyol Derg 2010; 10 (2): 143–9.
29. Kern MJ, Aguirre F, Bach R et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87: 500–11.
30. Kern MJ, Aguirre FV, Tatineni S et al. Enhanced coronary blood flow velocity during intra-aortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993; 21: 359–68.
31. Kumar A, Aronow WS, Vadnerkar A et al. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris. Am J Ther 2009; 16 (2): 116–8.
32. Lawson W, Hui J, Zheng Z et al. Improved exercise tolerance following enhanced extern countcrpulsation: cardiac or peripheral effect? Cardiology 1996; 87 (4): 271–5.
33. Lawson W, Hui J, Cohn P. Long-term prognosis of patients with angina treated with enhanced external counlerpulsation: five-year follow-up study. Clin Cardiol 2000; 23 (4): 254–8.
34. Lawson W, Kennard E, Holubkov R et al. Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure. Cardiology 2001; 96 (2): 78–84.
35. Lawson WE, Silver M, Barsness G et al. Comparison of abbreviated versus full course of enhanced external counterpulsation in heart failure patients with one-year follow-up. J Card Fail 2004; 10 (Suppl. 1): S84 (Abs).
36. Loh P, Cleland J, Louis A et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol 2008; 31 (4): 159–64.
37. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. JACC 2007; 50 (16): 1523–31.
38. Masuda D, Nohara R, Hirai T et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart 2001; 22 (16): 1451–8.
39. McClure S, Caruana L, Davie A et al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. Brit Med J 1998; 317 (7151): 516–9.
40. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counter pulsation. Circulation 2002; 106: 1237–42.
41. Michaels A, Linnemeier G, Soran O et al. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry). Am J Cardiol 2004; 93 (4): 461–4.
42. Michaels AD, Raisinghani A, Soran O et al. The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study. Am Heart J 2005; 150 (5): 1066–73.
43. Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996; 28: 1652–60.
44. Offergeld C, Werner D, Schneider M et al. Pneumatic external counterpulsation (PECP): a new treatment option in therapy refractory inner ear disorders? Laryngorhinootologie 2000; 79: 503–9.
45. Pettersson T, Bondesson S, Cojocaru D et al. One year follow-up of patients with refractory angina pectoris treated with enhanced external counter pulsation. BMC Cardiovascular Disorders 2006; 6: 28.
46. Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 2010; 85 (2): 180–95.
47. Shechter M, Matetzky S, Feinberg MS et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol 2003; 42 (12): 2090–5.
48. Soran O. Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 2002; 8 (4): 204–8.
49. Soran O, Kennard E, Kfoury A, Kelsey S. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). IEPR investigators. Am J Cardiol 2006; 97 (1): 17–20.
50. Feldman A, Silver M, Francis G et al. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure PEECH Investigators. JACC 2006; 48 (6): 1198–205.
51. Stys TV, Lawson W, Hui J et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002; 89 (7): 822–4.
52. Taguchi I, Ogawa K, Oida A et al. Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 2000; 86 (10): 1139–41.
53. Taguchi I, Ogawa K, Kanaya T et al. Effects of enhanced external counterpulsation on hemodynamics and its mechanism. Circulation 2004; 68 (11): 1030–34.
54. Tang WH, Francis GS. The year in heart failure. J Am Coll Cardiol 2010; 55 (7): 688–96.
55. Thomas HL, Brennan S, Cianci P, Silver MA. Enhanced external counter pulsation. Bringing the concept of the intraaortic balloon pump to the outpatient setting. Dimens Crit Care Nurs 2004; 23: 119–21.
56. Urano H, Ikeda H, Ueno T et al. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. JACC 2001; 37 (1) 93–9.
57. Werner D, Schneider M, Weise M et al. Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion. Am J Cardiol 1999; 84: 950–2.
58. Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J Afr 2007; 18 (3): 154–6.
59. Zhao SQ, Li Q, Wu T et al. [Correlation between B-natriuretic peptide and hemodynamics in patients with decompensated heart failure and clinical significance]. Zhonghua Xin Xue Guan Bing Za Zh 2005; 33 (6): 502–4.
60. Lawson W. Current use of enhanced external counterpulsation and patient selection. Clin Cardiol 2002; 25 (12): II16–II21 (Suppl. 2).
2. Бокерия Л.А. Ермоленко М.Л., Байрамукова М.Х. Наружная контрпульсация – эффективный метод лечения рефрактерной стенокардии. Бюлл. НЦ ССХ им. А.Н.Бакулева РАМН. 2005; 4: 5–10.
3. Бузиашвили Ю.И. Камардинов Д.Х., Мацкеплишвили С.Т. и др. Возможности наружной контрпульсации в комплексном лечении больных с ишемической болезнью сердца. Бюлл. НЦ ССХ им. А.Н.Бакулева РАМН. 2009; 1: 100–8.
4. Голухова, Е.З. Теряева Н.Б., Алиева А.М. Натрийуретические пептиды – маркеры и факторы прогноза при хронической сердечной недостаточности. Креативная кардиология. 2007; 1–2: 126–36.
5. Национальные рекомендации по диагностике и лечению ХСН (2-й пересмотр; утверждены съездом кардиологов РФ в октябре 2003 г.) Сердечная недостаточность. 2003; 4 (6): 276–97.
6. Терещенко С.Н. Павликова Е.П., Мерай И.А. Место мозгового натрийуретического пептида в диагностике сердечной недостаточности. Сердечная недостаточность. 2003; 2: 103–4.
7. Ancheta IB, Battie C, Cobb S et al. The impact of B-type natriuretic peptide, New York Heart Association classification and depression on quality of life in nonhospitalized heart failure patients. Prog Cardiovasc Nurs 2009; 24 (4): 124–30.
8. Applebaum RM, Kasliwal R, Tunick PA et al. Sequential external counterpulsation 61increases cerebral and renal blood flow. Am Heart J 1997; 133: 611–5.
9. Arora R, Chou T, Jain D et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. JACC 1999; 33 (7): 1833–40.
10. Arora R, Shah A. The role of enhanced external counterpulsation in the treatment of angina and heart failure. Can J Cardiol 2007; 23 (10): 779–81.
11. Bondesson S, Pettersson T, Ohlsson O et al. Effects on blood pressure in patients with refractory angina pectoris after enhanced external counterpulsation. Blood Press 2010. Epub ahead of print.
12. Bonnetti P, Barsness G, Keelan P et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. JACC 2003; 41 (10): 1761–8.
13. Bonetti P, Gadasalli S, Lerman A, Barsness G. Successful treatment of symptomatic coronary endothelial dysfunction with enhanced external counterpulsation. Clin Proc 2004; 79 (5): 690–2.
14. Bonetti P, Holmes D-Jr, Lerman A, Barsness G. Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? JACC 2003; 41 (11): 1918–25.
15. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168–75.
16. Brosche TA, Middleton SK, Boogaard RG. Enhanced external counter pulsation. Idimens Crit Care Nurs 2004; 23: 208–21.
17. Cai D, Wu R, Shao Y. Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med 2000; 23: 239–47.
18. Campbell AR, Satran D, Zenovich AG et al. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina. Am Heart J 2008; 156 (6): 1217–22.
19. Corson MA, James NL, Latta SE et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 1996; 79: 984–91.
20. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519–60.
21. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29 (19): 2388–442.
22. Dimmeler S, Fleming I, Fisslthaler B et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601–5.
23. Esmaeilzadeh M, Khaledifar A, Maleki M et al. Evaluation of left ventricular systolic and diastolic regional function after enhanced external counter pulsation therapy using strain rate imaging. Eur J Echocardiogr 2009; 10 (1): 120–6.
24. Estahbanaty G, Samiei N, Maleki M et al. Echocardiographic characteristics including tissue Doppler imaging after enhanced external counterpulsation therapy. Am Heart Hosp J 2007; 5 (4): 241–6.
25. Gorcsan J.-3rd, Crawford L, Soran O et al. Improvement in left ventricular performance by enhanced external counterpulsation in patients with heart failure. JACC 2000; 35: 230A (Suppl.).
26. Hashemi M, Hoseinbalam M, Khazaei M. Long-term effect of enhanced external counterpulsation on endothelial function in the patients with intractable angina. Heart Lung Circ 2008; 17 (5): 383–7.
27. Jessup M, Abraham W, Casey D et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119 (14): 1977–2016.
28. Karakiliç E, Kepez A, Abali G et al. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department. Anadolu Kardiyol Derg 2010; 10 (2): 143–9.
29. Kern MJ, Aguirre F, Bach R et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87: 500–11.
30. Kern MJ, Aguirre FV, Tatineni S et al. Enhanced coronary blood flow velocity during intra-aortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993; 21: 359–68.
31. Kumar A, Aronow WS, Vadnerkar A et al. Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris. Am J Ther 2009; 16 (2): 116–8.
32. Lawson W, Hui J, Zheng Z et al. Improved exercise tolerance following enhanced extern countcrpulsation: cardiac or peripheral effect? Cardiology 1996; 87 (4): 271–5.
33. Lawson W, Hui J, Cohn P. Long-term prognosis of patients with angina treated with enhanced external counlerpulsation: five-year follow-up study. Clin Cardiol 2000; 23 (4): 254–8.
34. Lawson W, Kennard E, Holubkov R et al. Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure. Cardiology 2001; 96 (2): 78–84.
35. Lawson WE, Silver M, Barsness G et al. Comparison of abbreviated versus full course of enhanced external counterpulsation in heart failure patients with one-year follow-up. J Card Fail 2004; 10 (Suppl. 1): S84 (Abs).
36. Loh P, Cleland J, Louis A et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol 2008; 31 (4): 159–64.
37. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. JACC 2007; 50 (16): 1523–31.
38. Masuda D, Nohara R, Hirai T et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart 2001; 22 (16): 1451–8.
39. McClure S, Caruana L, Davie A et al. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. Brit Med J 1998; 317 (7151): 516–9.
40. Michaels AD, Accad M, Ports TA, Grossman W. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counter pulsation. Circulation 2002; 106: 1237–42.
41. Michaels A, Linnemeier G, Soran O et al. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry). Am J Cardiol 2004; 93 (4): 461–4.
42. Michaels AD, Raisinghani A, Soran O et al. The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study. Am Heart J 2005; 150 (5): 1066–73.
43. Niebauer J, Cooke JP. Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996; 28: 1652–60.
44. Offergeld C, Werner D, Schneider M et al. Pneumatic external counterpulsation (PECP): a new treatment option in therapy refractory inner ear disorders? Laryngorhinootologie 2000; 79: 503–9.
45. Pettersson T, Bondesson S, Cojocaru D et al. One year follow-up of patients with refractory angina pectoris treated with enhanced external counter pulsation. BMC Cardiovascular Disorders 2006; 6: 28.
46. Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc 2010; 85 (2): 180–95.
47. Shechter M, Matetzky S, Feinberg MS et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol 2003; 42 (12): 2090–5.
48. Soran O. Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 2002; 8 (4): 204–8.
49. Soran O, Kennard E, Kfoury A, Kelsey S. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). IEPR investigators. Am J Cardiol 2006; 97 (1): 17–20.
50. Feldman A, Silver M, Francis G et al. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure PEECH Investigators. JACC 2006; 48 (6): 1198–205.
51. Stys TV, Lawson W, Hui J et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol 2002; 89 (7): 822–4.
52. Taguchi I, Ogawa K, Oida A et al. Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 2000; 86 (10): 1139–41.
53. Taguchi I, Ogawa K, Kanaya T et al. Effects of enhanced external counterpulsation on hemodynamics and its mechanism. Circulation 2004; 68 (11): 1030–34.
54. Tang WH, Francis GS. The year in heart failure. J Am Coll Cardiol 2010; 55 (7): 688–96.
55. Thomas HL, Brennan S, Cianci P, Silver MA. Enhanced external counter pulsation. Bringing the concept of the intraaortic balloon pump to the outpatient setting. Dimens Crit Care Nurs 2004; 23: 119–21.
56. Urano H, Ikeda H, Ueno T et al. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. JACC 2001; 37 (1) 93–9.
57. Werner D, Schneider M, Weise M et al. Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion. Am J Cardiol 1999; 84: 950–2.
58. Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J Afr 2007; 18 (3): 154–6.
59. Zhao SQ, Li Q, Wu T et al. [Correlation between B-natriuretic peptide and hemodynamics in patients with decompensated heart failure and clinical significance]. Zhonghua Xin Xue Guan Bing Za Zh 2005; 33 (6): 502–4.
60. Lawson W. Current use of enhanced external counterpulsation and patient selection. Clin Cardiol 2002; 25 (12): II16–II21 (Suppl. 2).
Авторы
Ю.И.Бузиашвили, С.Т.Мацкеплишвили, Э.Ф.Тугеева, Д.Х.Камардинов, М.Б.Ушерзон, А.З.Рахимов, Е.М.Суркичин, В.П.Алимов, М.А.Джалилов
Научный Центр сердечно-сосудистой хирургии им. А.Н.Бакулева РАМН, Москва
Scientific Center for Cardiovascular Surgery named ANBakulev RAMS, Moscow
Научный Центр сердечно-сосудистой хирургии им. А.Н.Бакулева РАМН, Москва
________________________________________________
Scientific Center for Cardiovascular Surgery named ANBakulev RAMS, Moscow
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.